izpis_h1_title_alt

Erythropoietin and its angiogenic activity
ID Kimáková, Patrícia (Author), ID Solár, Peter (Author), ID Solárová, Zuzana (Author), ID Komel, Radovan (Author), ID Debeljak, Nataša (Author)

.pdfPDF - Presentation file, Download (623,64 KB)
MD5: 7D3672B9EF8E9899CD14524C747E0C64
URLURL - Source URL, Visit http://www.mdpi.com/1422-0067/18/7/1519 This link opens in a new window

Abstract
Erythropoietin (EPO) is the main hematopoietic hormone acting on progenitor red blood cells via stimulation of cell growth, differentiation, and anti-apoptosis. However, its receptor (EPOR) is also expressed in various non-hematopoietic tissues, including endothelium. EPO is a pleiotropic growth factor that exhibits growth stimulation and cell/tissue protection on numerous cells and tissues. In this article we review the angiogenesis potential of EPO on endothelial cells in heart, brain, and leg ischemia, as well as its role in retinopathy protection and tumor promotion. Furthermore, the effect of EPO on bone marrow and adipose tissue is also discussed.

Language:English
Keywords:erythropoietin, erythropoietin receptor, cancer, endothelial, angiogenesis
Work type:Article
Typology:1.02 - Review Article
Organization:MF - Faculty of Medicine
Publication status:Published
Publication version:Version of Record
Year:2017
Number of pages:14 str.
Numbering:Vol. 18, iss. 7, art. 1519
PID:20.500.12556/RUL-131076 This link opens in a new window
UDC:616-006
ISSN on article:1422-0067
DOI:10.3390/ijms18071519 This link opens in a new window
COBISS.SI-ID:33325785 This link opens in a new window
Publication date in RUL:22.09.2021
Views:558
Downloads:140
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:International journal of molecular sciences
Shortened title:Int. j. mol. sci.
Publisher:MDPI
ISSN:1422-0067
COBISS.SI-ID:2779162 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.
Licensing start date:13.07.2017

Secondary language

Language:Slovenian
Keywords:eritropoetin, receptor eritropoetina, rak

Projects

Funder:Other - Other funder or multiple funders
Funding programme:Ministry of Education of the Slovak
Project number:VEGA 1/0394/15

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back